NCT04054986View on ClinicalTrials.gov

Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 9, 2019

Primary Completion Date

September 18, 2020

Study Completion Date

September 18, 2020

Conditions
Breast Cancer
Interventions
DIAGNOSTIC_TEST

F-Var3 PET/CT

Participants will undergo up to 5 serial F-Var3 PET/CT scans within 25 minutes of the injection of 18F-Var3, 30, 60, 120 and 240 minutes after injection of the 18FVar3.

OTHER

Blood draw

Collection of blood for research tests before the injection, 30, 60, 120 and 240 min after the injection.

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT04054986 - Study of the Imaging Agent 18F-Var3 in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter